Comparison Overview
Novartis

Novartis
Novartis Campus, Basel, 4002, CH
Last Update: 04/08/2026
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...

Hikma Pharmaceuticals
1 New Burlington Place, London, W1S 2HR, GB
Last Update: 03/04/2026
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospita...
Compliance Ranges Comparison

Novartis







Hikma Pharmaceuticals






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Novartis has 34.64% fewer incidents than the average of same-industry companies with at least one recorded incident.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Hikma Pharmaceuticals in 2026.
Incident History - Novartis (X = Date, Y = Severity)
Novartis cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Hikma Pharmaceuticals (X = Date, Y = Severity)
Hikma Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Novartis

Hikma Pharmaceuticals
FAQ
Latest Global CVEs
Pcapng file parser crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
X.509IF protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
H.245 protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
BUSMASTER file parser abnormal exit in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service
Kerberos protocol dissector crash in 4.6.0 to 4.6.7 and 4.4.0 to 4.4.18 allows denial of service